|
Hadjeri M, Barbier M, Ronot X. Modulation of Pglycopretein mediated multidrog resistance by flavonoid derivatives and analogues [J]. Medicinal Chemistry, 2003, (11):2125.
|
|
Wierstra I, Alves J. FOXM1, a typical proliferation-associated transcription factor [J]. Biological Chemistry, 2007, (12):1257.
|
|
Costa R H. FoxM1 dances with mitosis [J]. Nature Cell Biology, 2005(2):108.
|
|
Petrovic V, Costa R H, Lau L F. FoxM1 regulates growth factor-induced expression of kinase-interacting stathmin (KIS) to promote cell cycle progression [J]. Journal of Biological Chemistry, 2008(1):453.
|
|
Chen Y J, Dominguez-Brauer C, Wang Z. A conserved phosphorylation site within the forkhead domain of FoxMlB is required for its activation by cyclin CDK1 [J]. Journal of Biological Chemistry, 2009, (44):30695.
|
|
Kwok J M, Myatt S S, Marson C M. Tbiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression [J]. Molecular Cancer Therapeutics, 2008(7):2022.
|
|
Wang Z, Ahmad A, Banerjee S. FoxM1 isa novel target of a natural agent in pancreatic cancer [J]. Pharmaceutical Research, 2010(6):1159.
|
|
Ning Y, Li Q, Xiang H. Apoptosis induced by 7 difluoromcthoxyl-5, 4'-di-n-octyl genistein via the inactivation of FoxM1 in ovarian cancer cells [J]. Oncology Reports, 2012.
|
|
Fu XH, Wang L, Zhao H. Synthesis of genistein derivatives and determination of their protective effects against vascular endothclial cell damages caused by hydrogen peroxide [J]. Bioorganic and Medicinal Chemistry Letters, 2008(2):513.
|
|
Xie Z H, Quan M F, Liu F. 5-allyl-7-gen-diflu oromethoxy chrysin enhances TRAIL-induced apoptosis in human lung carcinoma A549 cells [J]. BMC Cancer, 2011.322.
|
|
Laoukili J, Stahl M, Medema R H. FoxM1:at the crossroads of ageing and cancer [J]. Biochimica Et Biophysica Acta, 2007(1):92.
|
|
Francis R E, Myatt S S, Krol J. FoxM1 is a downstream target and marker of HER2 overexpression in breast cancer [J]. International Journal of Oncology, 2009(1):57.
|
|
Gemenetzidis E, Bose A, Riaz A M. FOXM1 upregu lation is an early event in human squamous cell carcinoma and it is enhanced by nicotine during malignant transfomation [J]. PLoS One, 2009(3):e4849.
|
|
McGovern U B, Francis R E, Peck B. Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer [J]. Molecular Cancer Therapeutics, 2009(3):582.
|
|
Zhou B B, Bartek J. Targeting the checkpoint kinases:chemosensitization versus chemoprotection [J]. Nature Reviews Cancer, 2004(3):216.
|
|
Cheung C H, Chen H H, Kuo C C. Survivin counter acts the therapeutic effect of microtubule de-stabilizers by stabilizing tubulin polymers [J]. Molecular Cancer Therapeutics, 2009.43.
|
下载:
苏公网安备 32100302010246号
